Bromfenac Sodium and Insulin glargine, recombinant Subcutaneous
Determining the interaction of Bromfenac Sodium and Insulin glargine, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: bromfenac ophthalmic
Brand name: BromSite, Prolensa, Xibrom, Bromday
Synonyms: Bromfenac (ophthalmic)
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Bromfenac Sodium-Insulin glulisine
- Bromfenac Sodium-Insulin Glulisine (Cartridges and Pens)
- Bromfenac Sodium-Insulin Glulisine (Vials)
- Bromfenac Sodium-Insulin glulisine Subcutaneous
- Bromfenac Sodium-Insulin human inhaled Inhalation
- Bromfenac Sodium-Insulin human regular Injection
- Insulin glargine, recombinant Subcutaneous-Bromhist PDX
- Insulin glargine, recombinant Subcutaneous-Bromhist-PDX Syrup
- Insulin glargine, recombinant Subcutaneous-Bromo Seltzer
- Insulin glargine, recombinant Subcutaneous-Bromocriptine
- Insulin glargine, recombinant Subcutaneous-Bromocriptine (Cycloset)
- Insulin glargine, recombinant Subcutaneous-Bromocriptine (Parlodel)